Entries by PCS

Agreement between laboratory‑based and non‑laboratory‑based Framingham risk score in Southern Iran

Abstract Introduction: Estimation of the risk of cardiovascular diseases (CVD), may lead to prophylactic therapies. This study aims to compare and evaluate the agreement between CVD prediction of Iran Package of Essential Non-communicable Disease (IraPEN) and Framingham risk score (FRS). Methods: All 40-79 years old participants in the Yazd Health Study who did not have a history […]

Agreement between laboratory-based and non-laboratory-based Framingham risk score in Southern Iran

Fatemeh Rezaei, Mozhgan Seif, Abdullah Gandomkar, Mohammad Reza Fattahi & Jafar Hasanzadeh* Cardiovascular Diseases (CVDs) are one of the leading causes of death globally1. The annual mortality of CVDs has been predicted to increase from 17.5 million in 2012 to 22.2 million by 2030. Then, CVDs would be the number one cause of death and […]